Chemical Structure : BAY-1436032
CAS No.: 1803274-65-8
Catalog No.: PC-60292Not For Human Use, Lab Use Only.
BAY-1436032 (BAY1436032) is a potent, selective, orally available inhibitor of pan-mutant IDH1 with IC50 of 15 nM for both IDH1 R132H and R132C, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $78 | In stock | |
10 mg | $118 | In stock | |
25 mg | $218 | In stock | |
50 mg | $358 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BAY-1436032 (BAY1436032) is a potent, selective, orally available inhibitor of pan-mutant IDH1 with IC50 of 15 nM for both IDH1 R132H and R132C, respectively.
BAY-1436032 shows no effect on wild-type IDH1; strongly reduces 2-HG levels in cells carrying IDH1-R132H, -R132C, -R132G, -R132S and -R132L mutations.
BAY-1436032 significantly prolongs survival of mice intracerebrally transplanted with human astrocytoma carrying the IDH1R132H mutation.
M.Wt | 489.54 | |
Formula | C26H30F3N3O3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
3-(2-((4-(trifluoromethoxy)phenyl)amino)-1-((1R,5R)-3,3,5-trimethylcyclohexyl)-1H-benzo[d]imidazol-5-yl)propanoic acid |
1. Pusch S, et al. Acta Neuropathol. 2017 Apr;133(4):629-644.
2. Chaturvedi A, et al. Leukemia. 2017 Oct;31(10):2020-2028.
3. Gokul S, et al. CNS Neurol Disord Drug Targets. 2017;16(6):636-637.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright